Enhanced Efficacy of Chemotherapy by Addition of Immune Checkpoint Inhibitors in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung: A Real-World Analysis

Background: Large Cell Neuroendocrine Carcinoma (LCNEC) is a high-grade malignancy with limited treatment options. Despite promising results of immunotherapy in non-small cell and small cell lung cancers, its benefit in LCNEC remains elusive. Methods: We included 24 patients diagnosed with stage IV...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Lingbin, Cao, Biwei, Ji, Rui, Chen, Dung-Tsa, Laber, Damian A., Shafique, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622985/
https://www.ncbi.nlm.nih.gov/pubmed/37928431
http://dx.doi.org/10.7150/jca.87052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622985/
https://www.ncbi.nlm.nih.gov/pubmed/37928431
http://dx.doi.org/10.7150/jca.87052

Ejemplares similares